NCT02836938
Completed
Not Applicable
Breath Volatile Organic Compounds Patterns of Lung Transplant Patients With Chronic Lung Allograft Dysfunction
Prof. Dr. Jens Hohlfeld1 site in 1 country75 target enrollmentJune 2016
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Lung Allograft Dysfunction (CLAD)
- Sponsor
- Prof. Dr. Jens Hohlfeld
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- Concentration of exhaled breath volatile organic compounds
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
It's the aim of this study to clarify, whether the non-invasive assessment of breath can serve as a novel clinical tool to assist in the diagnosis of CLAD. If different stages of BOS can be discriminated by the level of certain VOCs than there would also be a potential to actually predict the development at an early stage and would enable an earlier intervention.
Investigators
Prof. Dr. Jens Hohlfeld
Prof. Dr.
Fraunhofer-Institute of Toxicology and Experimental Medicine
Eligibility Criteria
Inclusion Criteria
- •Outpatient bilateral lung transplant recipients including combined transplants
Exclusion Criteria
- •Active Smoking Oxygen therapy Infection with multi or pan-resistant bacteria
Outcomes
Primary Outcomes
Concentration of exhaled breath volatile organic compounds
Time Frame: one sample will be collected between 6 month and 20 years after lung transplantation
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Not Applicable
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in EthiopiaMalariaNCT02793414Menzies School of Health Research
Completed
Not Applicable
Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer PatientsEsophageal CancerNCT06453993Benaroya Research Institute46
Completed
Not Applicable
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?Lung CancerNCT06034730Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari60
Completed
Not Applicable
New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Metabolic Dysfunction-associated Steatohepatitis (MASH)NCT06647095General University Hospital, Prague172
Completed
Not Applicable
The Evaluation of a Noninvasive Respiratory Monitor in Intubated InfantsRespiratory ComplicationsNCT02899351Boston Children's Hospital30